Sjögren's Syndrome Symptoms: Dry Eyes, Mouth & More | Johns Hopkins

Added:

The Sicca-Centric Bias and Seronegative Sjögren's Controversy

While traditional clinical descriptions focus heavily on hallmark 'sicca' symptoms (dry eyes and mouth) as the primary indicators of Sjögren's syndrome, a growing perspective in rheumatology challenges this definition. Critics argue that a 'sicca-centric' model leads to underdiagnosis or delayed diagnosis of patients who present first with severe systemic manifestations—such as small fiber neuropathy, interstitial lung disease, or renal issues—without prominent dryness. Furthermore, there is significant debate surrounding 'seronegative' cases. Many patients suffer from chronic dry eyes, mouth, and fatigue but lack diagnostic autoantibodies (like Anti-SSA/SSB) or positive lip biopsies. Some experts argue that labeling these cases as Sjögren's pathologizes non-autoimmune conditions, such as age-related exocrine decline, autonomic dysfunction, or medication side effects, which require entirely different management strategies. This alternative viewpoint advocates for a shift away from symptom-based classification toward precise, biomarker-driven definitions of the disease.

Basic understanding of the human immune system and the general mechanism of autoimmune diseases, where the body's defense system mistakenly attacks its own healthy tissues.
The anatomy and function of the exocrine system, particularly the lacrimal (tear-producing) and salivary glands, and their role in maintaining moisture.
The concept of systemic inflammation and how immune-mediated inflammation can manifest as widespread symptoms like fatigue and joint pain.
Diagnostic methods for Sjögren's syndrome, including blood tests for specific autoantibodies (Anti-SSA and Anti-SSB), Schirmer's test, and salivary gland biopsies.
The clinical distinction between Primary Sjögren's (occurring alone) and Secondary Sjögren's (occurring alongside other autoimmune diseases like Lupus or Rheumatoid Arthritis).
Current management and treatment strategies, ranging from symptomatic relief (artificial tears and saliva stimulants) to systemic immunosuppressive therapies.
Long-term monitoring and serious potential complications of Sjögren's syndrome, such as an elevated risk of developing non-Hodgkin lymphoma.
241.3K views2.1Klikes3:15@JohnsHopkinsRheumatologyOriginal Release: 2018-07-17

Sjögren's Syndrome is characterized by persistent, daily dryness of the eyes and mouth that significantly impairs daily functioning, requiring frequent artificial tears and water sipping; beyond these hallmark symptoms, patients commonly experience disabling joint pain, brain fog, and severe fatigue, while approximately 20% develop serious complications such as peripheral neuropathy affecting nerves in the skin and limbs, and 5-10% face an increased risk of lymphoma development.